Provided by Tiger Fintech (Singapore) Pte. Ltd.

RESONANCE HEALTH LTD

0.044
+0.0024.76%
Volume:457.90K
Turnover:20.46K
Market Cap:20.71M
PE:-11.56
High:0.046
Open:0.045
Low:0.044
Close:0.042
52wk High:0.068
52wk Low:0.033
Shares:470.76M
Float Shares:296.43M
Volume Ratio:2.37
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.004
EPS(LYR):-0.004
ROE:-17.05%
ROA:-5.19%
PB:2.21
PE(LYR):-11.56

Loading ...

Company Profile

Company Name:
RESONANCE HEALTH LTD
Exchange:
ASX
Establishment Date:
1987
Employees:
16
Office Location:
141 Burswood Road,Level 1,Burswood,Western Australia,Australia
Zip Code:
6100
Fax:
61 8 9286 5399
Introduction:
Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials, including clinical measurement, as well as project and data management services, such as reporting, administration, and support. The company serves clinicians for the diagnosis and management of human diseases; and pharmaceutical companies for their clinical trials. Resonance Health Limited is headquartered in Burswood, Australia.